Home > Drug Search >
  • company_query: Aptevo
  •   > 
Drug Filter
Category:
chemistry (24) biology (32)
Status:
Approved (22) NDA Filing (1) BLA Filing (1) Phase Ⅲ (3) Phase Ⅱ (21) Phase Ⅰ (8)
Clinical Stage:
Pending (6) Active (17) Discontinued (11)
Bio-Type:
Gene therapy (2) Vaccine (8) Blood extraction (2) Allergen extract (1) Recombinant enzyme (7) Recombinant cytokines (1) Recombinant hormone (1) Whole antibody (3) Fab fragment (1)
Indication:
Acute lymphoblastic leukaemia (ALL) (1) Acute rejection in renal transplantation (1) Allergic rhinoconjunctivitis (1) Amyotrophic lateral sclerosis (ALS) (1) Bladder cancer (1) Breast cancer (1) Hyperkalaemia (1) Chronic lymphocytic leukemia (CLL) (1) Crohn's disease (1) Cholera (1) Facial acne vulgaris (1) Gaucher's disease (GD) (2) HBV infection (1) Heart failure (1) Hematopoietic stem cell transplantation (HSCT) (1) HIV infection (2) Hypercholesterolemia (1) Melanoma (3) Multiple myeloma (MM) (3) Multiple sclerosis (MS) (3) Niemann-Pick diseases (1) Non small cell lung cancer (NSCLC) (2) Non-Hodgkin’s lymphoma (NHL) (3) Osteoarthritis (OA) (1) Pancreatic cancer (1) Parkinson's disease (PD) (2) Postmenopausal osteoporosis (1) Primary hypercholesterolemia (1) Prostate cancer (3) Psoriasis (1) Rheumatoid arthritis (RA) (2) Varicella zoster virus infections (1) Seasonal allergic rhinitis (1) Secondary hyperparathyroidism (HPT) (1) Solid tumours (3) Thyroid cancer (1) Shigella infection (1) Type 2 diabetes (1) Ulcerative colitis (1) Cervical intraepithelial neoplasia (1) Fabry disease (1) Rejection of renal transplantation (1) Hyperlipoproteinaemia type IIa (1) Familial hypercholesterolemia (1) Heterozygous familial hypercholesterolemia (1) Age-related macular degeneration (AMD) (1) Primary hyperlipidemia (1) Cervical carcinoma (1) Diagnostic agents (1) Malaria (1) Neutropenia (1) Condylomata acuminata (1) Kaposi's sarcoma (1) Renal carcinoma (1) Glycogen storage disease type II (1) Mucopolysaccharidosis II (Hunter syndrome) (1) Mucopolysaccharidosis I (1) Hereditary antithrombin deficiency (1) Focal segmental glomerulosclerosis (1) Hyperphosphatemia (2) Glioma (1) Graft versus host disease (1) Gout (1) Mesothelioma (1) Pulmonary fibrosis (1) Bacterial infection (1) High-grade cervical intraepithelial neoplasia (2) Human papillomavirus infections (HPV) (1) Cervical dysplasia (1) AIDS-related chronic diarrhea (1)
Country:
US (13) EU (2)
Aprv. Year:
1995 (2) 1998 (1) 1999 (1) 2000 (1) 2001 (2) 2003 (1) 2006 (2) 2007 (1) 2008 (1) 2012 (2) 2014 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top